Search filters

List of works by Deborah Hurst

A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma

scientific article published on 01 December 2006

A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia

scientific article

Anemia and hemoglobinopathies in Southeast Asian refugee children

scientific article published on 01 May 1983

Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States

scientific article published on 20 March 2015

Bleeding disorders in Noonan syndrome: three case reports and review of the literature

scientific article

Butyrate analogues modulate globin gene expression in human and ovine erythroid cells

scientific article published on 01 January 1989

Clinical development of recombinant factor VIII (rFVIII, Kogenate).

scientific article

Differentiation of homozygous hemoglobin E from compound heterozygous hemoglobin E-beta O-thalassemia by hemoglobin E mutation analysis

scientific article published on May 1, 1992

Epitope specificity and functional characterization of factor VIII inhibitors

scientific article published on January 1995

Evaluation of recombinant factor VIII (Kogenate) stability for continuous infusion using a minipump infusion device

scientific article published in November 1998

Growth retardation in sickle-cell disease treated by nutritional support

scientific article published on 01 April 1985

Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study Group

scientific article published in January 1999

Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigation

scientific article published in April 2004

Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group.

scientific article published in April 1994

In vivo recovery with products of very high purity--assay discrepancies

scientific article published in July 1998

Newborn screening for sickle cell disease and other hemoglobinopathies. Northern California's experience.

scientific article

Newborn screening for sickle cell disease: effect on mortality

scientific article

Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion

scientific article published on 22 May 2003

Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-hodgkin's lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical response

scientific article published on April 2004

Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma

scientific article published on 07 March 2014

Recombinant human GM-CSF treatment of neutropenia in glycogen storage disease-1b

scientific article

Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80 degrees C terminal dry heat treatment in patients with haemophilia A.

scientific article published on May 2000

Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia

scientific article published on 01 July 1989

The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.

scientific article

Transfusion of infants with activation of erythrocyte T antigen

scientific article published on 01 December 1989

Paulina is supported by:

About Paulina

Help